Skip to main content
    D

    DBV Technologies (DBVT)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $10.27
    -0.74 (-6.76%)

    Market Cap: $692.19M

    Last updated: Nov 17, 2026 at 11:03 AM ET

    Earnings

    Upcoming Estimates

    Report date not yet scheduledPeriod ending Dec 31, 2026
    EPS Consensus-0.09
    Range-0.09 - -0.09
    2 analysts
    Revenue Consensus
    828.20K
    Range803.60K - 861.00K
    2 analysts
    Report date not yet scheduledPeriod ending Mar 31, 2027
    EPS Consensus-0.11
    Range-0.13 - -0.10
    3 analysts
    EPS Revisions
    0
    1
    30d
    EPS Estimate DriftChange to current
    90d ago-0.20+42.3%
    60d ago-0.20+42.3%
    30d ago-0.20+42.8%
    7d ago-0.110.0%
    Current-0.11
    Revenue Consensus
    499.75K
    RangeN/A
    4 analysts
    Last 12 of 38 reported quarters and 2 upcoming estimates
    PeriodReportedEst.RangeSurpriseB/MAnalystsRevisionsYoY
    Mar 27EST
    Date TBD
    --0.11-0.13 - -0.10--3
    0
    1
    30d
    -
    Dec 26EST
    Date TBD
    --0.09-0.09 - -0.09--2--
    Sep 26
    Reported Oct 28
    -0.70-0.60N/A--3
    0
    1
    30d
    -
    Jun 26
    Reported Jul 16
    -0.60-0.12N/A--3
    0
    1
    30d
    -
    Mar 26
    Reported Apr 30
    -0.09-0.12-0.21 - -0.06--4
    1
    1
    30d
    -
    Dec 25
    Reported Mar 27
    -0.20-0.19-0.24 - -0.09--5
    1
    1
    30d
    -
    Sep 25
    Reported Oct 28
    -0.21-0.29-0.37 - -0.22--3
    1
    0
    30d
    -
    Jun 25
    Reported Jul 29
    -0.27-0.16-0.25 - -0.11--3
    1
    0
    30d
    -
    Mar 25
    Reported Apr 30
    -0.23-0.22-0.22 - -0.22--1
    0
    1
    30d
    -
    Dec 24
    Reported Mar 27
    -0.21-0.21-0.21 - -0.21--1
    1
    0
    30d
    -
    Sep 24
    Reported Nov 6
    -1.49-1.64N/A--2
    No revisions (30d)
    -
    Jun 24
    Reported Jul 30
    -1.57-2.65-3.10 - -1.00--3
    No revisions (30d)
    -
    Mar 24
    Reported May 7
    -5.20-4.12N/A--3
    No revisions (30d)
    -
    Dec 23
    Reported Mar 7
    -0.06-0.23N/A--3
    No revisions (30d)
    -

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCF-3.67xFCF Yield-27.23%
    Profitability
    Profit Margin0.00%Operating Margin-5577.00%
    ROE-205.80%ROIC-130.26%
    Financial Health
    Debt/Equity0.10xInterest CoverageN/A
    Current Ratio3.24xQuick Ratio3.24x
    Trading Statistics
    Beta-0.21Avg Volume382.98K
    52-Week High$26.1852-Week Low$8.63

    Technical Indicators Dashboard

    As of Nov 16, 2026, the price is 4.7% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 47.5, in the neutral range between 30 and 70.

    Moving Averages

    SMA 10$10.75
    SMA 20$10.28
    SMA 50$10.78
    SMA 200$16.31
    EMA 10$10.74
    EMA 20$10.52
    EMA 50$11.07
    EMA 200$14.10

    MACD

    Line: 0.14Signal: -0.03Hist: 0.16

    ADX

    ADX: 19.5+DI: 25.4-DI: 25.1

    Aroon & PSAR

    Aroon Up88.0
    Aroon Down16.0
    PSAR$9.84

    Bollinger Bands

    Upper Band$11.80
    Lower Band$8.75
    %B Position2966%(Upper)
    Band Width0.50

    RSI (14-Day)

    Neutral
    47.5

    Momentum Oscillators

    Stoch %K62.7
    Stoch %D77.6
    Williams %R-57.5
    ROC (10d)13.5%
    Momentum1.22
    CCI (20d)23.9
    MFI (14d)43.6

    Volatility Measures

    ATR (14d)$0.74(7.2%)
    StdDev (20d)0.76
    Hist Vol79.0%(High)

    Volume Flow

    VWAP$10.46
    OBV-2.4M
    AD Line-12.4M
    CMF (20d)-0.014

    Volume Metrics

    Avg Vol (20d)388.6K
    Vol Ratio0.4x(Low)
    VWMA (20d)$10.20

    Pivot Points

    R3$12.57
    R2$12.08
    R1$11.55
    Pivot Point$11.06
    S1$10.52
    S2$10.03
    S3$9.50

    Advanced Oscillators

    TSI5.08
    Ultimate Osc57.2
    KST43.91

    Financial Performance

    Related GNG Research

    No research available

    Be the first to write about DBVT

    News

    DBVT Valuation

    GNG's valuation label for DBVT is Undervalued.

    P/FCF
    -3.7x
    P/B
    5.5x
    All DBVT metrics

    DBVT Profitability: Margins, ROIC and FCF

    DBV Technologies (DBVT) has an operating margin of -5577.0% and a net margin of 0.0%. It posts -130.3% ROIC.

    Operating margin
    -5577.0%
    Net margin
    0.0%
    ROIC
    -130.3%
    ROE
    -205.8%
    FCF yield
    -27.2%
    DBVT financial statements

    DBV Technologies Competitors

    The companies most similar to DBV Technologies (DBVT) include Vir Biotechnology, 4D Molecular Therapeutics and Valneva SE ADR.

    Sector: Healthcare

    Companies most similar to DBV Technologies

    DBVT Analyst Ratings

    DBV Technologies (DBVT) has a Buy consensus from 7 analysts: 6 Buy or Strong Buy, 0 Hold and 1 Sell or Strong Sell.

    Consensus
    Buy
    Analysts
    7
    Strong Buy
    1
    Buy
    5
    Hold
    0
    Sell
    1
    Strong Sell
    0

    DBVT Bull Case vs Bear Case

    Bull case

    • 85.7% of DBVT's analyst ratings are Buy or Strong Buy.

    Bear case

    • DBVT's quarterly revenue changed -42.9% year over year.

    DBVT Earnings Call

    The latest DBVT earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Updated Oct 30, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology

    Frequently Asked Questions About DBVT

    Does DBVT pay dividends?

    DBV Technologies (DBVT) does not currently pay a regular dividend.

    What is DBVT's market cap?

    DBV Technologies (DBVT) has a market capitalization of $692.19M with a current stock price of $10.27.

    How do analysts rate DBVT stock?

    7 analysts cover DBV Technologies (DBVT): 1 rate it Strong Buy, 5 Buy, 0 Hold, 1 Sell and 0 Strong Sell, a consensus of Buy.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.